Nyrada, Inc.ASX: NYR

PROTECT-MI Phase IIa Clinical Trial Update No 3

· Issued by Nyrada, Inc. via ASX

Filed with ASX · · 5 pages · English

On 6ix: 6ix.com/news/protect-mi-phase-iia-clinical-trial-update-no-3

Release

Page 1 Nyrada Inc. Level 22/23, Salesforce Tower, 180 George Street, Sydney NSW 2000 ARBN 625 401 818 16 October 2026 Sydney, Australia PROTECT-MI Phase IIa Clinical Trial Update #3 Highlights: • Four trial sites now activated, including highly experienced STEMI research centres at Northern...

Nyrada, Inc. on 6ix

Earlier from Nyrada

Later from Nyrada

All Nyrada news releases